vimarsana.com

மஜும்தர் ஷா மருத்துவ அடித்தளம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Kiran Shaw expresses disappointment over SEBI s ruling

Kiran Shaw expresses disappointment over SEBI s ruling Kiran Shaw expresses disappointment over SEBI s ruling Biocon Chief Kiran Mazumdar Shaw has tweeted her displeasure about a SEBI judgement on Allegro Capital. In its judgement, SEBI barred Allegro Capital and its MD and CEO, Kunal Kashyap, from participating in Indian security markets for one year over insider trading in the probe over Biocon s scrip movement in 2018. Taking to Twitter, Shaw tweeted, What does MSMF (Mazumdar Shaw Medical Foundation) have to do with Biocon?  The officer concerned needs to explain her convoluted hypothesis.  SEBI needs to act rationally in insider trading judgements. When a Twitter user added screenshots to point towards the relationship, Shaw replied that Mazumdar Shaw Medical Foundation had zero links to Biocon.

SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares

SEBI bars Allegro Capital, its CEO over insider trading in Biocon shares IANS 09 July 2021 The Securities and Exchange Board of India (SEBI) has barred brokerage firm Allegro Capital Pvt Ltd and its Chairman and CEO Kunal Ashok Kashyap from the securities market for a period of one year over involvement in insider trading in the scrip of Biocon Ltd.   Kunal Ashok Kashyap and M/s Allegro Capital Private Limited shall not buy, sell or otherwise deal in the securities market in any manner whatsoever or access the securities market, directly or indirectly, for a period of one year from the date of this order, it said.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.